{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:10:52Z","timestamp":1780089052047,"version":"3.54.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this manuscript, we discuss the use of neuromodulatory techniques such as intrathecal therapy (IT) and spinal cord stimulation (SCS) for cancer pain in neuro-oncology patients. Currently, cancer pain management relies on oral opioids, which have a number of systemic side effects particularly in a chronic setting. An escalation of pain therapy for pain relief, such as neuromodulation, is necessary to improve neuro-oncology patients\u2019 quality of life. The paper highlights the need for more comprehensive pain management for patients during and after receiving cancer therapies. IT allows analgesics to bypass the blood-brain barrier (BBB), generating rapid and effective analgesia with fewer side effects than oral drug administration. SCS can interrupt pain signals via electrical stimulation of the dorsal columns of the spinal cord. Here we present rationale and highlight individualized treatment options for these neuromodulatory techniques\u2019 use in a neuro-oncological setting.<\/jats:p>","DOI":"10.1093\/noajnl\/vdaf062","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:23:05Z","timestamp":1742228585000},"page":"iii37-iii46","source":"Crossref","is-referenced-by-count":0,"title":["Surgical techniques for patients with cancer-related neuropathic pain"],"prefix":"10.1093","volume":"8","author":[{"given":"Erica","family":"Gillespie","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Arizona College of Medicine , Tucson, AZ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Bouchal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Arizona College of Medicine , Tucson, AZ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University School of Medicine , Stanford, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6488-9692","authenticated-orcid":false,"given":"Julie G","family":"Pilitsis","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Arizona College of Medicine , Tucson, AZ ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"3","key":"2026052916370737900_CIT0001","doi-asserted-by":"crossref","first-page":"1700611","DOI":"10.1183\/13993003.00611-2017","article-title":"Pain control in thoracic oncology","volume":"50","author":"Peeters-Asdourian","year":"2017","journal-title":"Eur Respir J."},{"issue":"8","key":"2026052916370737900_CIT0002","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, Version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw."},{"issue":"2","key":"2026052916370737900_CIT0003","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11916-014-0474-8","article-title":"History and present state of targeted intrathecal drug delivery","volume":"19","author":"Rizvi","year":"2015","journal-title":"Curr Pain Headache Rep."},{"issue":"2","key":"2026052916370737900_CIT0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/107327480000700205","article-title":"Interventional treatment of cancer pain: The fourth step in the World Health Organization analgesic ladder","volume":"7","author":"Miguel","year":"2000","journal-title":"Cancer Control"},{"issue":"1","key":"2026052916370737900_CIT0005","first-page":"E695","article-title":"Revisiting the WHO analgesic ladder for surgical management of pain","volume":"22","author":"McGuire","year":"2020","journal-title":"AMA J Ethics"},{"issue":"F1000 Faculty Rev","key":"2026052916370737900_CIT0006","doi-asserted-by":"crossref","first-page":"945","DOI":"10.12688\/f1000research.10817.1","article-title":"Recent advances in understanding and managing cancer pain","volume":"6","author":"Chwistek","year":"2017","journal-title":"F1000Res"},{"issue":"4","key":"2026052916370737900_CIT0007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2298\/ACI0404015S","article-title":"Cancer pain (neurosurgical management)","volume":"51","author":"Slavik","year":"2004","journal-title":"Acta Chir Iugosl."},{"issue":"5","key":"2026052916370737900_CIT0008","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurom.2022.01.023","article-title":"Spinal cord stimulation in the treatment of cancer pain: A retrospective review","volume":"25","author":"Crowther","year":"2022","journal-title":"Neuromodulation"},{"issue":"1","key":"2026052916370737900_CIT0009","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1213\/00000539-199307000-00022","article-title":"Management of intractable pain with percutaneous epidural spinal cord stimulation: Differences in pain-relieving effects among diseases and sites of pain","volume":"77","author":"Shimoji","year":"1993","journal-title":"Anesth Analg"},{"issue":"5","key":"2026052916370737900_CIT0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.neurom.2023.03.006","article-title":"Spinal cord stimulation increases chemoefficacy and prevents paclitaxel-induced pain via CX3CL1","volume":"26","author":"Sivanesan","year":"2023","journal-title":"Neuromodulation"},{"issue":"7","key":"2026052916370737900_CIT0011","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.21873\/anticanres.17088","article-title":"Advances in spinal neuromodulation for chemotherapy-induced peripheral neuropathy","volume":"44","author":"Gupta","year":"2024","journal-title":"Anticancer Res."},{"issue":"11","key":"2026052916370737900_CIT0012","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.48.11.1135","article-title":"Motor conduction velocity in the human spinal cord: Slowed conduction in multiple sclerosis and radiation myelopathy","volume":"48","author":"Snooks","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3-4","key":"2026052916370737900_CIT0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3121\/cmr.2008.813","article-title":"Spinal cord stimulation as a treatment option for intractable neuropathic cancer pain","volume":"6","author":"Yakovlev","year":"2008","journal-title":"Clin Med Res."},{"issue":"4","key":"2026052916370737900_CIT0014","first-page":"554","article-title":"Spinal cord stimulation to treat unresponsive cancer pain: A possible solution in palliative oncological therapy","volume":"12","author":"Paolini","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"2026052916370737900_CIT0015","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2022.7.FOCUS22330","article-title":"Spinal cord stimulation for treatment of chronic neuropathic pain in adolescent patients: A single-institution series, systematic review, and individual participant data meta-analysis","volume":"53","author":"Bakr","year":"2022","journal-title":"Neurosurg Focus."},{"issue":"2","key":"2026052916370737900_CIT0016","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"5","key":"2026052916370737900_CIT0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0025-6196(12)61647-4","article-title":"Treatment of cancer-related pain: When orally administered medications fail","volume":"69","author":"Lamer","year":"1994","journal-title":"Mayo Clin Proc."},{"key":"2026052916370737900_CIT0018","doi-asserted-by":"crossref","first-page":"114338","DOI":"10.1016\/j.addr.2022.114338","article-title":"Intrathecal delivery and its applications in leptomeningeal disease","volume":"186","author":"Khang","year":"2022","journal-title":"Adv Drug Deliv Rev."},{"key":"2026052916370737900_CIT0019","doi-asserted-by":"crossref","first-page":"96","DOI":"10.12688\/f1000research.2-96.v1","article-title":"Intrathecal Drug Delivery (ITDD) systems for cancer pain","volume":"2","author":"Bhatia","year":"2013","journal-title":"F1000Res"},{"issue":"3","key":"2026052916370737900_CIT0020","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.36076\/ppj.2011\/14\/E283","article-title":"Center For Pain Relief, Inc. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain","volume":"14","author":"Deer","year":"2011","journal-title":"Pain Physician."},{"issue":"6","key":"2026052916370737900_CIT0021","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neurom.2023.05.001","article-title":"Intrathecal drug delivery systems for cancer pain control: Insights on current contemporary practices in the US","volume":"26","author":"Goel","year":"2023","journal-title":"Neuromodulation"},{"issue":"5","key":"2026052916370737900_CIT0022","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/annonc\/mdi156","article-title":"An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)","volume":"16","author":"Smith","year":"2005","journal-title":"Ann Oncol."},{"issue":"2","key":"2026052916370737900_CIT0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/SPC.0000000000000549","article-title":"Neuromodulation techniques for cancer pain management","volume":"15","author":"Magee","year":"2021","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"2026052916370737900_CIT0024","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11916-013-0388-x","article-title":"Intrathecal therapy for chronic pain: Current trends and future needs","volume":"18","author":"Hayek","year":"2014","journal-title":"Curr Pain Headache Rep."},{"issue":"11","key":"2026052916370737900_CIT0025","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/j.pain.0000000000001957","article-title":"Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: A multicenter, randomized, single-blind, controlled noninferiority trial","volume":"161","author":"Ma","year":"2020","journal-title":"Pain."},{"issue":"2","key":"2026052916370737900_CIT0026","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40122-020-00169-1","article-title":"Triple intrathecal combination therapy for end-stage cancer-related refractory pain: A prospective observational study with two-month follow-up","volume":"9","author":"Puntillo","year":"2020","journal-title":"Pain Ther"},{"issue":"1","key":"2026052916370737900_CIT0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11916-009-0092-z","article-title":"Current developments in intraspinal agents for cancer and noncancer pain","volume":"14","author":"Lawson","year":"2010","journal-title":"Curr Pain Headache Rep."},{"issue":"1","key":"2026052916370737900_CIT0028","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA."},{"issue":"2","key":"2026052916370737900_CIT0029","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1213\/ANE.0000000000004425","article-title":"Intrathecal drug delivery systems for cancer pain: An analysis of a prospective, multicenter product surveillance registry","volume":"130","author":"Stearns","year":"2020","journal-title":"Anesth Analg."},{"issue":"2","key":"2026052916370737900_CIT0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nic.2019.01.008","article-title":"Headache and brain tumor","volume":"29","author":"Hadidchi","year":"2019","journal-title":"Neuroimaging Clin N Am."},{"issue":"8","key":"2026052916370737900_CIT0031","doi-asserted-by":"crossref","first-page":"351","DOI":"10.12998\/wjcc.v2.i8.351","article-title":"Intracerebroventricular opiate infusion for refractory head and facial pain","volume":"2","author":"Lee","year":"2014","journal-title":"World J Clin Cases"},{"key":"2026052916370737900_CIT0032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000509623","article-title":"Targeted drug delivery (intrathecal and intracranial) for treatment of facial pain","volume":"35","author":"Dupoiron","year":"2020","journal-title":"Prog Neurol Surg."},{"issue":"2","key":"2026052916370737900_CIT0033","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuchi.2020.10.003","article-title":"Neuroablative surgical treatments for pain due to cancer","volume":"67","author":"Farrell","year":"2021","journal-title":"Neurochirurgie."},{"issue":"5","key":"2026052916370737900_CIT0034","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/pm\/pnw211","article-title":"Interventional pain management for sacroiliac tumors in the oncologic population: A case series and paradigm approach","volume":"18","author":"Hutson","year":"2017","journal-title":"Pain Med."},{"issue":"9","key":"2026052916370737900_CIT0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0147-0272(77)80010-X","article-title":"Neurosurgical control of pain in the patient with cancer","volume":"1","author":"Perret","year":"1977","journal-title":"Curr Probl Cancer."},{"issue":"3","key":"2026052916370737900_CIT0036","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00002508-199709000-00013","article-title":"Palliation of intractable cancer pain by MRI-guided cingulotomy","volume":"13","author":"Wong","year":"1997","journal-title":"Clin J Pain."},{"issue":"3","key":"2026052916370737900_CIT0037","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.hoc.2018.01.002","article-title":"Cancer pain syndromes","volume":"32","author":"Portenoy","year":"2018","journal-title":"Hematol Oncol Clin North Am."},{"key":"2026052916370737900_CIT0038","first-page":"603","article-title":"Resolution of chronic migraine headaches with intrathecal ziconotide: A case report","volume":"8","author":"Narain","year":"2015","journal-title":"J Pain Res"},{"issue":"3","key":"2026052916370737900_CIT0039","first-page":"e23714","article-title":"Intrathecal administration of ziconotide as a potential treatment for chronic migraines","volume":"14","author":"Holden","year":"2022","journal-title":"Cureus"},{"issue":"6","key":"2026052916370737900_CIT0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0269216307081130","article-title":"Cervical intrathecal analgesia for head and neck\/upper limb cancer pain: Six case reports","volume":"21","author":"Baker","year":"2007","journal-title":"Palliat Med."},{"key":"2026052916370737900_CIT0041","article-title":"Neoplastic Lumbosacral Plexopathy","volume-title":"StatPearls","author":"Harish Bindiganavile","year":"2023"},{"issue":"3","key":"2026052916370737900_CIT0042","doi-asserted-by":"crossref","first-page":"251","DOI":"10.36076\/ppj.2013\/16\/251","article-title":"Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center","volume":"16","author":"Engle","year":"2013","journal-title":"Pain Physician."},{"key":"2026052916370737900_CIT0043","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/B0-44-306557-8\/50232-X","article-title":"Chapter 230 - Neurosurgical Treatment and Implantable Devices","volume-title":"Office Practice of Neurology","author":"Thorkild Vad Norregaard","year":"2003","edition":"2nd Ed"},{"issue":"6","key":"2026052916370737900_CIT0044","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1200\/JCO.1995.13.6.1509","article-title":"Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients","volume":"13","author":"Sanders","year":"1995","journal-title":"J. Clin Oncol"},{"issue":"1-2","key":"2026052916370737900_CIT0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF01407774","article-title":"Stereotactic mesencephalic tractotomy in the treatment of chronic cancer pain","volume":"99","author":"Frank","year":"1989","journal-title":"Acta Neurochir (Wien)."},{"key":"2026052916370737900_CIT0046","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/neurosurgery\/21.CN_suppl_1.334","article-title":"Stereotactic anterior cingulate lesions for persistent pain: A report on 68 cases","volume":"21","author":"Hurt","year":"1974","journal-title":"Clin Neurosurg."},{"issue":"6","key":"2026052916370737900_CIT0047","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0269216315574260","article-title":"Interest of repetitive transcranial magnetic stimulation of the motor cortex in the management of refractory cancer pain in palliative care: Two case reports","volume":"29","author":"Nizard","year":"2015","journal-title":"Palliat Med."},{"issue":"8","key":"2026052916370737900_CIT0048","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.clinph.2016.05.016","article-title":"Value of transcranial direct-current stimulation of the motor cortex for the management of refractory cancer pain in the palliative care setting: A case report","volume":"127","author":"Nguyen","year":"2016","journal-title":"Clin Neurophysiol."},{"issue":"7","key":"2026052916370737900_CIT0049","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.neurol.2021.07.014","article-title":"Spinal cord stimulation for neuropathic pain","volume":"177","author":"Fontaine","year":"2021","journal-title":"Rev Neurol (Paris)."},{"key":"2026052916370737900_CIT0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jconrel.2022.06.067","article-title":"Noninvasive ultrasonic induction of cerebrospinal fluid flow enhances intrathecal drug delivery","volume":"349","author":"Aryal","year":"2022","journal-title":"J Control Release."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdaf062\/67423002\/vdaf062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/Supplement_3\/iii37\/67423002\/vdaf062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/Supplement_3\/iii37\/67423002\/vdaf062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:37:21Z","timestamp":1780087041000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/8\/Supplement_3\/iii37\/8529698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":50,"journal-issue":{"issue":"Supplement_3","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdaf062","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,20]]}}}